Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Capital Expenditures (2021 - 2026)

Valneva SE (VALN) posted Capital Expenditures of -$289174.2 for Q1 2026, down 103.2% sequentially from $9.0 million in Q4 2025, and up 80.39% YoY from -$160303.6 in Q1 2025.

Analysis

Valneva SE (VALN) Capital Expenditures (2021 - 2026) Analysis & Trends

Valneva SE has reported Capital Expenditures for 6 years, with the latest figure at -$289174.2 in Q1 2026.

  • Quarterly Capital Expenditures rose 80.39% year-over-year to -$289174.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 63.7% YoY) and the FY2025 annual result came in at $5.1 million, down 65.71% from the prior year.
  • Capital Expenditures declined to -$289174.2 in Q1 2026 per VALN's latest filing, from $9.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $7.8 billion in Q3 2023 and troughed at -$7.8 billion in Q2 2023.
  • A 5-year average of $3.6 million and a median of -$1.4 million in 2025 frame the typical range for Capital Expenditures.
  • The widest YoY moves for Capital Expenditures: up 118555.13% in 2023, down 111166.8% in 2023.
  • Over 5 years, Capital Expenditures stood at $52.8 million in 2022, then sank by 53.95% to $24.3 million in 2023, then grew by 4.97% to $25.5 million in 2024, then plunged by 64.61% to $9.0 million in 2025, then sank by 103.2% to -$289174.2 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$289174.2, $9.0 million, and -$780928.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -397,527.75
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -397,527.75
Mar 31, 2026 -289,174.18
Dec 31, 2025 -1.26 Mn
Sep 30, 2025 -780,928.80
Jun 30, 2025 -1.43 Mn
Mar 31, 2025 -1.47 Mn
Dec 31, 2024 -4.12 Mn
Sep 30, 2024 -6.48 Mn
Jun 30, 2024 424,293.71
Mar 31, 2024 -4.89 Mn
Dec 31, 2023 -6.32 Mn
Sep 30, 2023 7.79 Bn
Jun 30, 2023 -7.80 Bn
Mar 31, 2023 -4.13 Mn
Dec 31, 2022 -6.91 Mn
Sep 30, 2022 -6.58 Mn
Jun 30, 2022 -7.01 Mn
Mar 31, 2022 -10.53 Mn
Dec 31, 2021 -26.60 Mn
Sep 30, 2021 -35.14 Mn